These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 10776778

  • 1. Spironolactone and congestive heart-failure.
    Georges B, Beguin C, Jadoul M.
    Lancet; 2000 Apr 15; 355(9212):1369-70. PubMed ID: 10776778
    [No Abstract] [Full Text] [Related]

  • 2. Tolerability of spironolactone as adjunctive treatment for heart failure in patients over 75 years of age.
    Dinsdale C, Wani M, Steward J, O'Mahony MS.
    Age Ageing; 2005 Jul 15; 34(4):395-8. PubMed ID: 15955761
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Elderly heart failure patients with drug-induced serious hyperkalemia.
    Vanpee D, Swine CH.
    Aging (Milano); 2000 Aug 15; 12(4):315-9. PubMed ID: 11073352
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serious adverse events experienced by patients with chronic heart failure taking spironolactone.
    Berry C, McMurray JJ.
    Heart; 2001 Apr 15; 85(4):E8. PubMed ID: 11250985
    [Abstract] [Full Text] [Related]

  • 10. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.
    Tamirisa KP, Aaronson KD, Koelling TM.
    Am Heart J; 2004 Dec 15; 148(6):971-8. PubMed ID: 15632880
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Spironolactone and potassium].
    Kjeldsen K.
    Ugeskr Laeger; 2004 Nov 22; 166(48):4392; author reply 4392-3. PubMed ID: 15587639
    [No Abstract] [Full Text] [Related]

  • 14. [Dangerous hyperkalemia as sequelae of new treatment strategies of heart failure].
    Fuster D, Frey FJ, Ferrari P.
    Praxis (Bern 1994); 2000 Dec 07; 89(49):2073-6. PubMed ID: 11190849
    [Abstract] [Full Text] [Related]

  • 15. [Late drug-induced hyperkalemia in a patient with congestive heart failure].
    Konopa J, Bułło B, Rutkowski B.
    Przegl Lek; 2005 Dec 07; 62(7):732-3. PubMed ID: 16463712
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hyperkalaemia and impaired renal function in patients taking spironolactone for congestive heart failure: retrospective study.
    Svensson M, Gustafsson F, Galatius S, Hildebrandt PR, Atar D.
    BMJ; 2003 Nov 15; 327(7424):1141-2. PubMed ID: 14615339
    [No Abstract] [Full Text] [Related]

  • 18. Hyperkalemia and Acute Kidney Injury with Spironolactone Use Among Patients with Heart Failure.
    Secora AM, Shin JI, Qiao Y, Alexander GC, Chang AR, Inker LA, Coresh J, Grams ME.
    Mayo Clin Proc; 2020 Nov 15; 95(11):2408-2419. PubMed ID: 33153631
    [Abstract] [Full Text] [Related]

  • 19. [Increased breast cancer risk caused by spironolactone?].
    Fanta S.
    Dtsch Med Wochenschr; 2012 Sep 15; 137(38):1840. PubMed ID: 23133848
    [No Abstract] [Full Text] [Related]

  • 20. Hyperkalaemia in congestive heart failure patients using ACE inhibitors and spironolactone.
    Cruz CS, Cruz AA, Marcílio de Souza CA.
    Nephrol Dial Transplant; 2003 Sep 15; 18(9):1814-9. PubMed ID: 12937229
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.